Coriolus Lengthens Life in Breast, Colon, and Gastric Cancer

Posted on Jun 12, 2013 in My Cancer Type, Research

For every 11 people who breast, colon, or gastric cancer who take coriolus, 1 more person will be alive 5 years later. This result is from a metanalysis of 13 clinical trials.

To put this effect in perspective, let’s compare it to some other therapies used in these cancers.

Breast: To extend 3 years of life for 1 woman, 8-17 women have to take Herceptin at a total cost of $450,000 to $4 million.

Colon: To extend 3 years of life for 1 person with stage III cancer, 14 have to take FOLFOX chemotherapy for 24 weeks.

Clearly, coriolus is a safe, effective, and affordable integrative therapy.